ACRS Aclaris Therapeutics
- 2.570
- +0.060+2.39%
- 2.550
- -0.020-0.78%
Aclaris Therapeutics所有资讯
Aclaris Therapeutics | 4：持股变动声明-高管 Monahan Joseph
Aclaris Therapeutics | 4：持股变动声明-高管 Loerop James
Aclaris Therapeutics | 4：持股变动声明-高管 Balthaser Kevin
Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4：持股变动声明-高管 Monahan Joseph
Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal
Aclaris Therapeutics | D：发行公告
Aclaris Therapeutics | 4：持股变动声明-高管 Davis Hugh M.
Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 3：首次持股声明-股东 Biosion, Inc.
Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Biosion, Inc.(9.5%)
Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Rock Springs Capital Management LP(6.32%),Rock Springs Capital LLC(6.32%)等
Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Vivo Opportunity Fund Holdings, L.P.(7.4%),Vivo Opportunity, LLC(7.4%)等
Aclaris Therapeutics | 4：持股变动声明-董事 Mehra Anand
Aclaris Therapeutics | 3：首次持股声明-高管 Davis Hugh M.
Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Kenneth Griffin(0.5%),Citadel Advisors LLC(0.3%)等
Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal
Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Millennium Management LLC(4.2%),Millennium Group Management LLC(4.2%)等
Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4：持股变动声明-高管 Balthaser Kevin
暂无数据